Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5887_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
02.09.2026
Размер:
21 Мб
Скачать
86
https://t.me/medicina_free
extract 125 mg, ashwagandha extract 300 mg or identical placebo twice daily for eight weeks as a capsule. A signicant improvement in the PSS scale was observed in 58 volunteers (who completed the trial) with a marked drop in blood cortisol lev­els as well as improved sleep pattern. Another clinical study focused on treating an obese adult population with 300 mg of ashwagandha root extract (>5% withanolides) twice a day for 10 weeks. This has led to decreased levels of cortisol in the blood, body weight and basic metabolic index, as well as decreased body fat. A preclinical study in rats showed decreased corticosterone levels in the hippocampus in the stress model (Baitharu et al, 2013). The other mechanism by which WS alleviates stress is by immune stimulation and anti-inammatory effects. This leads to an increase in the number of peripheral T cells (CD3, CD4 and CD8 populations), interleukin-2 (IL-2), interferon gamma (INF-γ) and the number of polymorphonuclear leukocytes, which are downregulated in stress. Preclinical studies using WS extracts and with­anolides-rich extracts (2.7%) on stress induced in rats by cold restraint stress and forced swimming-induced stress, showed antistress activity with increased white blood cell counts, neutrophils, lymphocytes and eosinophils (Anju, 2011; Puri and Puroh it, 2016). Panax ginseng, another antistress plant of the family Araliaceae, contains active phytoconstituents that reduce stress including ginsenoside Rb1 and Rg3. Stress results in decreased brain brain-derived neurotrophic factor (BDNF) lev­els altering heat shock protein – 70 in the hippocampus. BDNF is synthesised in the endoplasmic reticulum and plays its functions by binding on the tropomyosin recep­tor kinase B receptor further activating the signal transduction cascade to promote neuroplasticity, neuronal survival and differentiation (Lee and Kim, 2010).
Clinical study of Korean red ginseng (KRG) in two high-stress occupations, that is, nurses and reghters aged 20–60 years were included in the study (Baek et al,
2019). The stress levels of these volunteers and cognition were assessed using the Beck Depression Inventory and the Stress Response Inventory. Chronic stress in volunteers had raised levels of cortisol and catecholamine, adrenaline and reduced triglycerides. Treatment with KRG for 2 g/day of KRG (LAX-101) or placebo for 6weeks showed reduced levels of cortisol and epinephrine and normalised triglycer­ides. This is assumed to be the possible mechanism for central nervous system (CNS) stabilisation. Further, KRG was found to contain Rb1, 6.44 mg/g; Rb2, 2.25 mg/g; Rc, 2.68 mg/g; Rd, 0.50 mg/g; Re, 2.08 mg/g; Rf, 0.89 mg/g; Rg1, 3.21 mg/g; Rg2,
0.29 mg/g; Rg3, 0.18 mg/g. Treatment with Rb1 also increases the levels of ther­mal shock protein 70 and BDNF that have neuroprotective and anti-stress properties (Kim et al, 2013). A pre-clinical study consisting of total ginseng panax saponins (TSPG) was studied on chronic unpredictable mild stress (CUMS)-induced stress in rats. They were treated with TSPG (50 mg/kg/day, 100 mg/kg/day) during the entire modelling period. TSPG was found to improve depressive behaviour and to exhibit neuroprotection. TSPG inhibited pro-inammatory cytokines, as well as P38 and Jun N-terminal kinase (JNK) protein phosphorylation in the hippocampus, indicat­ing signicant antidepressant and antistress activity. Camellia sinensis L. commonly called green tea from the Theaceae family. The active phytoconstituent, L-theanine is thenon-proteinogenic amino acid, passes freely through the blood-brain barrier, acts by reduction of presynaptic glutamate release, increased inhibitory neurotrans­mitter GABA, and enhanced glycine and dopamine release (Kakuda et al, 2008;
NeuroPhytomedicine
Molecular Mechanism of Action of Phytoconstituents
https://t.me/medicina_free
Shen et al, 2019; Yamada et al, 2007). Clinical study on fth-year college students (n = 20) of the school of pharmaceutical sciences, practising outside the university at the hospital or a drug store, for 11 weeks, where they were administered theanine (200 mg, twice a day, after breakfast and lunch). These were assessed for anxiety using a state anxiety inventory test. At the end of the study, treatment with théanine supplementation was found to be benecial in suppressing psychosocial stress. It was assumed that theanine improved the HPA axis (Unno et al, 2013).
87
5.3 PHYTOCONSTITUENTS USED FOR ANXIETY
People who experience anxiety have difculty with their sleep habits, their ability to focus and their ability to interact with others. Anxiety disorders like panic disorder are characterised by recurrent, unprovoked panic attacks that leave sufferers feeling extremely anxious, approaching doom, dizzy and short of breath (Markowitz et al,
1989). Agoraphobia, generalised anxiety disorder (GAD), social phobia and phobias of animals, heights, elevators, blood or injections are examples of other anxiety dis­orders (Ballenger, 2007; Craske et al, 1989; Magee et al, 1996; Schweizer, 1995). Due to the varied character of anxiety disorders, concomitant conditions including stress, diabetes, depression or hereditary factors could contribute to their aetiology (Amray et al, 2019). Serotonin (5-hydroxytryptamine; 5-HT), GABA, noradrenaline (NE), adrenocorticotropic hormone (ACTH), CRH, neuropeptide-Y and cholecystokinin (CCK), main excitatory amino acid, glutamate, N-methyl-D aspartate (NMDA), alpha-amino-3-hydroxy-5-methylisoxazole propionate (AMPA) and kainic acid are a few neurotransmitters involved in the development of anxiety. Serotonergic dys­function leads to an aberrant 5-HT release and/or reuptake regulation or abnormal 5-HT signal response. A key stress-response mechanism that causes anxiety is the LC noradrenergic system that releases epinephrine during stress and works in tan­dem with the corticotropin-releasing factor (CRF) system. CRF neurons are found in the paraventricular nucleus, where they mediate the HPA axis’s activity in response to stress, which raises plasma cortisol levels and increases CRF. The serotonergic and noradrenergic systems are interconnected and together play a prime role in the regulation of mood and anxiety (Bremner et al, 2010). The inhibitory neurotrans­mitter, GABA inuences the level of dopamine, 5-HT and NMDA. Thus, NMDA antagonists and non-NMDA type receptors can reduce excitatory glutamate recep­tor activity and possess anxiolytic effects (LeDoux, 1994)). Alternately, increasing GABA neurotransmission can reduce the output of the excitatory system. Thus, for effective control of the behavioural and physiological responses related to anxiety, a balance between NE, 5-HT, glutamate receptor-mediated excitement and GABA receptor-mediated inhibition should exist. Selective 5-HT reuptake inhibitors (SSRI) and 5-HT-norepinephrine reuptake inhibitors are the rst-line treatments for anxiety.
An alarming amount of people are becoming overly dependent on synthetic phar­maceuticals to treat or relieve anxiety disorders, yet there are still many people who prefer herbal remedies. Important phytochemicals acting on the CNS are being iden­tied, including saponins, alkaloids, polyphenols, triterpenes, essential oils, fatty acids and avonoids. The phytoconstituents from families of herbs – Solanaceae, Piperaceae, Hypericaceae, Plantaginaceae, Passioraceae, Araliaceae, Lamiaceae,
88 NeuroPhytomedicine
https://t.me/medicina_free
Caprifoliaceae, Turneraceae, Elaeocarpaceae, Lamiaceae, Asteraceae and Apiaceae are commonly used as anti-anxiety remedies. According to the European Medicines Agency (EMA) and the National Agency of Sanitary Surveillance (ANVISA),
Withania somnifera L., Piper methysticum, Hypericum perforatum L., Bacopa monnieri L., Passiora incarnata L. and Panax ginseng are safe herbal remedies. Ocimum sanctum L. also known as Tulsi contains eugenol (70%) as a major constitu-
ent. Clinical study carried out in patients suffering from generalised anxiety disorder were selected and given the ethanolic extract of Ocimum sanctum L. supplement (500 mg capsule, twice daily) for 60 days. On completion of the study, reduced stress, attenuated anxiety and negated depression attributing to the regulation of hypo­thalamohypophyseal-adrenocortical axis were noted (Bhattacharyya et al, 2008). OciBest, an extract of Ocimum sanctum L, having ociglycoside-I (hydroxychavicol glucoside/4-allyl-1-O-β-D-glucopyronosyl-2-hydroxybenzene; > rinic acid (>0.2% w/w) and triterpene acids (>2.5% w/w) was tested in 158 patients in a randomised, double-blind trial which exhibited antistress effects (Saxena et al,
2012). Eugenol treatment in rats exposed to restrain for 4 hours attenuated ulcer index and reduced cortisol without affecting NE and amelioration of HPA axis (Garabadu et al, 2011). The most commonly active phytoconstituents present in Melissa ofcinalis L. (Lamiaceae) also known as lemon herb are rosmarinic acid, ursolic acid and oleanolic acid is native to Europe and Asia and is responsible for its antianxiety effect. Clinical investigation in patients with anxiety and sleep disorder, supplemented with dried powder of aerial part of Melissa ofcinalis L. (3 g) for 56days showed improvement in anxiety score (Haybar et al, 2018). The author sug­gested its antianxiety effects attributed to its serotonergic activity, reduced cortisol level and its GABA transaminase inhibitory effect. The preclinical study in rats has proven that Melissa ofcinalis L. act by inhibiting GABA transaminase and shows promising anxiolytic effect (Bathala et al, 2012). Hypericum perforatum L. (Saint John’s Wort (SJW)) containing active phytoconstituents hypericin and hyper­forin is majorly used in anxiety disorder. Hypericin inhibits monoamine oxidase-A (MAO-A) and monoamine oxidase-B (MAO-B) enzymes and regulates dopamine levels. Hyperforin elevates the extracellular levels of 5-HT, dopamine, NE, GABA and L-glutamate. Passiora incarnata L. (Passion ower) contain active phytocon­stituents such as orientin, isoorientin, vitexin, isovitexin and chrysin shows antianxi­ety effect by its action on benzodiazepine and GABA receptors (Table 5.1).
0.1% w/w), rosma-
5.4 PHYTOCONSTITUENTS USED FOR DEPRESSION
Depression is a neuropsychiatric disorder characterised by anxiety, aggression, dementia and emotional imbalance. According to the World Health Organization, depression is considered the most prevalent among all neuropsychiatric disorders. Worldwide 322 million people are suffering from depression (Vasha et al, 2023). Lack of diagnosis makes depression a more severe form, resulting in loneliness and suicidal tendencies. Various studies have reported complications and comor­bidities associated with depression such as cardiovascular changes, constipation, colitis, erectile dysfunctions and thyroid problems. In severe cases, it may lead to MDD, Alzheimer’s disease and diabetes. Various synthetic drugs such as tricyclic
Molecular Mechanism of Action of Phytoconstituents
https://t.me/medicina_free
TABLE 5.1 Summary of Phytoconstituents Reported for Various Neuropsychiatric Disorders and Their Mechanism of Action.
S. No Antipsychotic Biological Source-Family Molecular Mechanism References
Antipsychotic
1. Vitegnoside Vitex negundo
(Lamiaceae)
2. Bergenin Securinega virosa
(Euphorbiaceae)
3. Alkaloid, saponin
glycoside, steroids, reducing sugar, resin and avonoid
4. Quercetin,
kaempferol
5. Saponins Crassocephalum
6. Flavonoids,
essential oils
7. Alpha lipoic acid Spinach/Spinacia oleracea
8. Silymarin Silybum marianum (L.)
9. Aleuronic acid Valeriana Ofcinalis L.
Albizia zygia (DC) (Leguminosae-
Mimosoideae)
Lonchocarpus cyanescens
(Fabaceae)
bauchiense
(Asteraceae)
Ocimum sanctum
(Lamiaceae)
(Amaranthaceae), brocolli,
tomato
Gaertn
(Asteraceae)
(Valerianaceae)
Antagonizes
dopaminergic activity.
Antidopaminergic activity on the melatonin MT1 and MT2 and promotes sleep onset.
Enhance glutamate and dopamine release in the limbic striatal regions.
Inhibition of hyperactivation caused by dopamine.
Blockade of dopamine D-2 receptors and GABAergic activation
Decreases dopamine levels and reduces oxidative stress.
Restore monoamines by modulation of 5HT3 receptor.
Block the reuptake of 5-HT into presynaptic 5-HT neurons.
GABA A receptor modulator.
(Abidin et al,
2015; Ahmed et al, 2014)
(Magaji et al,
2015)
(Amoateng et al,
2017; Kumbol et al, 2018)
(Arowona et al,
2014)
(Taïwe et al, 2012)
(Sharma et al,
2016)
(Perera et al, 2011)
(Karcı and Celik,
2020)
(Karcı and Celik,
2020; Kochlamazashvili et al, 2010)
(Continued)
89
90
https://t.me/medicina_free
NeuroPhytomedicine
TABLE 5.1
(Continued)
Summary of Phytoconstituents Reported for Various Neuropsychiatric Disorders and Their Mechanism of Action.
S. No Antipsychotic Biological Source-Family Molecular Mechanism References
10. Morin Morus alba (Moraceae)
11. Mitragynine Mitragyna speciosa (Rubiaceae)
12. Cannabidiol Cannabis sativa
(Cannabaceae)
Antidepressants
13. Curcumin
Chrysin Arctigenin Glycyrrhizic acid
14. Eugenol
Antiepilepsirine Palmatine Gallic acid β-Carotene Icariin Fisetin
15. Cinnamic
aldehyde Resveratrol Salvianolic acid B Ferulic acid Quercetin
Curcuma longa L.
(Zingiberaceae)
Apis dorsata (Apidae) Carthamus tinctorius L.
(Asteraceae)
Glycyrrhiza glabra L.
(Fabaceae)
Syzygium aromaticum
(Myrtaceae)
Albizzia julibrissin
(Fabaceae)
Berberis aristate
(Berberidiaceae)
Emblica ofcinalis
(Phylantheaceae)
Daucus carota subsp.
sativus (Apiaceae)
Epimedium grandiorum
(Berberidaceae)
Fragaria ananassa
(Rosaceae)
Cinnamomum verum
(Lauraceae)
Muscadine grapes
(Vitaceae) Salvia miltiorrhiza
(Danshen)
Attenuate neurochemical change and reduce ROS.
Inhibit dopamine-induced contractile response.
Activates 5-HT1A and glutamate receptor (NMDA), inhibit FAAH enzyme.
IDO/TDO
MAO-A
PG-E2
TNF-α and IL-Iβ;
Bcl-2 expression; NF-κB gene
expression.
(Ben-Azu et al,
2018)
(Vijeepallam et al,
2016)
(Xiang et al, 2022)
(Borges Filho et al,
2016; Seo et al, 2015; Temml et al, 2013; Wang et al,
2018)
(Tao et al, 2005)
(Yao et al, 2015)
(Continued)
Molecular Mechanism of Action of Phytoconstituents
https://t.me/medicina_free
91
TABLE 5.1
(Continued)
Summary of Phytoconstituents Reported for Various Neuropsychiatric Disorders and Their Mechanism of Action.
S. No Antipsychotic Biological Source-Family Molecular Mechanism References
16. Withaferin-A, withanolide
17. Asiatic acid, madecassic acid, asiaticoside, madecassoside and brahmic acid
18. Baicalin and wogonin
19. Carnosine, carnosic acid, carnosal, rosmanol, epirosmanol
(Lamiaceae)
Pavetta owariensis
(Rubiaceae)
Coccinia indica
(Cucurbitaceae)
Antistress
Withania somnifera
(Solanaceae)
Centella asiatica L. (Apiaceae)
Scutellaria baicalensis
(Lamiaceae)
Rosmarinus ofcinalis
(Lamiaceae)
ACTH and CORT;
CAT, SOD and GSH
peroxidase activities; MDA; IL-6, IL-1β and TNF-α; NLRP3 inammasome activation.
IL-1β, IL-6 and
TNF-α; ACTH and CORT; NF-κB activation; nNOS expression; IL-10; GR protein expression.
GSH; SOD and CAT
activity; 5-HT; Glu; IL-1β and TNF-α.
Reduction of
cortisol levels.
Increase upregulates receptor population in corpus striatum.
Decrease
oxidative stress.
Antioxidative activity, interact with GABA receptor, reduce serum levels of IL-2, corticosterone.
Modulate sympathetic nervous system and HPA axis, activate cholinergic activity (AchE activity) in PC12 cells via phosphorylation of ERK1/2.
(Archana and
Namasivayam, 1998; Jamalludin and Manshoor,
2022)
(Zakaria et al,
2023; Kalshetty et al, 2012)
(Lee et al, 2007)
(Kayashima et al,
2020)
(Continued)
92
https://t.me/medicina_free
NeuroPhytomedicine
TABLE 5.1
(Continued)
Summary of Phytoconstituents Reported for Various Neuropsychiatric Disorders and Their Mechanism of Action.
S. No Antipsychotic Biological Source-Family Molecular Mechanism References
20. Ginsenoside Rb1 and Rg3
21. L-Theanine Camellia sinensis
22. Rosalin (WS®
1375), Rodiolin, rosin, rosavin, rosarin and rosiridin
23. Apigenin Matricaria recutita
24. Rosmarinic acid Melissa ofcinalis
25. Rosmarinic acid triterpenoids, ursolic acid oleanolic acid
26. Triterpenes, derivatives of avones
27. Linalool and linalyl
acetate
Panax ginseng
(Araliaceae)
(Theaceae)
Rhodiola rosea
(Crassulaceae)
(Asteraceae)
(Lamiaceae)
Antianxiety
Melissa ofcinalis
(Lamiaceae)
Cimicifuga pregula L. Nutt (Ranunculaceae)
Lavandula angustifolia
Mill. (Lamiaceae)
Increased ACTH
and corticosterone.
Reduce presynaptic glutamate release, increase inhibitory neurotransmitter GABA and enhance glycine and dopamine release.
Normalise cortisol synthesis.
Afnity for benzodiazepine receptors, binds to GABA receptors, reduces the levels of the stress-induced ACTH.
Inhibits GABA transaminase activity and slow the degradation of GABA.
Inhibitor of rat brain
GABA transaminase.
Inhibited the
oxidative stress.
Act in the
hypothalamus
vasomotor centre, dopaminergic action.
Anxiolytic-like effect through 5-HT1A receptors.
(Huang et al,
2019)
(Sarris et al, 2019;
Unno et al, 2013)
(Emilija and
Quintela, 2022)
(Ebrahimi et al,
2022)
(Wang et al, 2022)
(Heydari et al,
2019)
(Fajemiroye et al,
2016)
(López et al, 2017)
(Continued)
Molecular Mechanism of Action of Phytoconstituents
https://t.me/medicina_free
93
TABLE 5.1
(Continued)
Summary of Phytoconstituents Reported for Various Neuropsychiatric Disorders and Their Mechanism of Action.
S. No Antipsychotic Biological Source-Family Molecular Mechanism References
28. Hypericin, hyperforin
29. Linalool and
β-pinene
30. Methyl isoeugenol
and oleanolic acid
31. Mesembrine, mesembranol, mesembrenol and mesembrenone
32. Bacopasides Bacopa monnieri
33. Benzo-avonoids Passiora incarnate
34. Eleutherosides, sennosides
Hypericum perforatum L. (Hypericaceae)
Litsea glaucescens
(Lauraceae)
Pimenta pseudocaryophyllus (Gomes), ChamguavaL. R.
Landrum
(Myrtaceae)
Sceletium tortuosum
(Aizoaceae )
(Scrophulariaceae)
(Passioraceae)
Eleutherococcus senticosus
(Araliaceae)
Selective inhibitor of MAO-A and MAO-B Inhibition of 5-HT, NE and DA uptake; antagonist of NMDA receptors; moderate interactions with the GABA A receptor, Suppression of the release of interleukin.
Interaction with the serotonergic 5-HT1A receptors, a2- and b-adrenoceptors and dopaminergic receptors D1.
Acts on 5-HT1A receptor.
Inhibitory effects on 5-HT reuptake, binds to gamma butyric acid (GABA).
Lower susceptibility to stress even before exposure.
Acts on benzodiazepine and GABA receptors, MAO enzyme inhibiting properties.
HPA axis regulation.
(Oliveira et al,
2016)
(Guzmán-
Gutiérrez et al,
2015)
(Fajemiroye et al,
2016)
(Carpenter et al,
2016)
(Calabrese et al,
2008; Sathyanarayanan et al, 2013)
(Dhawan et al,
2001)
(Lee and Rhee,
2017)
(Continued)
94
https://t.me/medicina_free
NeuroPhytomedicine
TABLE 5.1
(Continued)
Summary of Phytoconstituents Reported for Various Neuropsychiatric Disorders and Their Mechanism of Action.
S. No Antipsychotic Biological Source-Family Molecular Mechanism References
35. Ethanol extract of ower
36. Ginsenoside Rb1 Panax ginseng
37. Hydroalcoholic extract
38. Ginkgolide-A Ginkgo biloba
39. Baicalin, baicalein Scutellaria lateriora
40. Valerenic acid, valepotriates
41. Mother tincture Turnera aphrodisiaca
42. Riparin III Aniba riparia
43. Hydroethanolic extract of the aerial part
44. Clary (aromatic essential oil)
45. Root tincture Artemisia vulgaris
Echium amoenum
(Boraginaceae)
(Araliaceae)
Salvia reuterana
(Lamiaceae)
(Ginkgoaceae)
(Lamiaceae) Valeriana ofcinalis L.
(Caprifoliaceae)
(Passioraceae)
(Lauraceae)
Aloysia polystachya
(Verbenaceae)
Salvia sclarea
(Lamiaceae)
(Asteraceae)
Reduce oxidative stress and elevation of catecholamine levels.
Modulate monoamine neurotransmitter system, regulate the expression of neurotrophic factors, regulate HPA axis function, anti­inammatory action.
Acetylcholinesterase inhibitor, GABA receptor agonist.
Regulate dopamine, 5-HT and inammatory glial­derived proteins.
GABAA agonist
GABAA agonist
GABA agonist
Monoamine inhibition
Selective 5-HT reuptake inhibition.
Modulation of the dopaminergic pathway.
GABAA receptor modulation.
(Nouri et al, 2019)
(Bui et al, 2022)
(Rabbani et al,
2005)
(Deravi, 2022)
(Awad et al, 2003)
(Murphy et al,
2010)
(Kumar et al,
2008)
(Sousa et al, 2004)
(Carmona et al,
2019)
(Seol et al, 2010)
(Hernandez-Leon
et al, 2017; Khan et al, 2016)
(Continued)
Molecular Mechanism of Action of Phytoconstituents
https://t.me/medicina_free
95
TABLE 5.1
(Continued)
Summary of Phytoconstituents Reported for Various Neuropsychiatric Disorders and Their Mechanism of Action.
S. No Antipsychotic Biological Source-Family Molecular Mechanism References
46. Rutin Camellia sinensis (L.) Kuntze
(Theaceae)
47. Quercetin Chenopodium album
(Amaranthaceae)
48. Kaempferol,
quercetin alkaloid and avonoid
49. Honokiol Magnolia obovata
50. Eugenol,
1,8-cineole, 1,8-bisabolene
Sansevieria trifasciata
(Asparagaceae)
Ginkgo biloba
(Ginkgoaceae)
Elaeocarpus ganitrus
(Elaeocarpaceae )
(Magnoliaceae)
Ocimum sanctum
(Lamiaceae)
GABAA
receptors modulation.
Modulation of GABAergic and serotonergic system.
Modulation of molecular pathways such as NF-kB, PI3k/AKT, MAPK, Bcl2, Caspase 3 and VEGF.
Effects on GABA-benzodiazepine receptor, inhibitory activity on inammatory mediator.
Regulation of HPA
axis
(Hernandez-Leon
et al, 2017)
(Cárdenas-
Rodríguez et al,
2014)
(Kim et al, 2013)
(Ham et al, 2020)
(Bhattacharyya et
al, 2008)
51. Linalool and linalyl acetate
52. Apigenin Matricaria recutita
53. Linalool,
γ-terpinene, α-pinene
Abbreviations: Corticotropin-releasing hormone (CRH), dopamine (DA), nor-epinephrine (NE),
5- hydroxytryptamine (5-HT), gamma-aminobutyric acid (GABA), N-methyl-D-aspartate (NMDA), monoamine oxidase (MAO), hypothalamic–pituitary–adrenal (HPA) axis, corticotro­pin-releasing hormone (CRH), adrenocorticotropic hormone (ACTH), reactive oxygen species (ROS), acetylcholinesterase (AchE), fatty acid amide hydrolase (FAAH), tryptophan-2,3­dioxygenase (TDO), indole 2,3 amine dioxygenase (IDO), superoxide dismutase (SOD), catalase (CAT), tumour necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β), nuclear factor kappa b (NF-kb), mitogen-activated protein kinase (MAPK).
Lavandula angustifolia
Mill. (Lamiaceae)
Coriandrum sativum
(Apiaceae)
(Asteraceae)
Cortical sparing
effect.
Effect on
5-HT1A receptor.
Ligand for the central benzodiazepine receptors.
MAO-B inhibition.
(Caputo et al,
2018)
(Viola et al, 1995)
(Hosseini et al,
2021)